Current Market Information

Last Trade Price (LTP) 145.10 Updated Date 25 July, 2024 Change 0.00 % Open Price 145.10 Day's Range 145.10 - 145.10     Total Trade 0 Total Volume 0 Close Price 145.10 Previous Close Price 145.10 Market Capital in BDT (mn) 33518.100

Contact Information

Designation Name Mobile Number Email Chairman Mrs. Nurun Nahar Karim 01913397900 nkarim@beaconpharma.com.bd MD Mr. Mohammad Ebadul Karim 01713240344 ebadul@beaconpharma.com.bd CFO Mr. Md. Abdul Haque Sarder, FCS FCA 01713156222 sarder@beacongroup.com.bd Company Secretary Mr. Md. Sahabuddin FCS 01713156477 sahabuddin@beaconpharma.com.bd Office Address Beacon Business Centre, 9/B/2, Toyenbee Circular Road, Motijheel C/A, Dhaka-1000 Phone : 02-57165371-76 Fax : 02-57165379 Email : beacon@beaconpharma.com.bd Website : http://www.beaconpharma.com.bd Factory Address Beacon Pharmaceuticals Limited,Khathali, Bhaluka, Mymemsingh

Basic Information

Authorized Capital in BDT* (mn) 3,000.00 Paid-up Capital in BDT* (mn) 2,310.00 Face Value 10 Paid up Share 231000000     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 2010 Debut Trade Date 12 August, 2010 Type of Instrument     52 Week's Range 136.80 - 279.10 Year End 202306 Reserve / Surplus(mn) 3632.02 Remarks Tk 1,068,173,214 Revaluation Surplus has been added to Reserve & Surplus. Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-May, 2024 39.863 0 35.405 0 24.732 As on 30-Apr, 2024 39.863 0 35.208 0 24.929 As on 31-Mar, 2024 39.863 0 36.41 0 23.727 As on 30-Jun, 2024 (year ended) 39.863 0 39.07 0 21.067     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Nov 15, 2023 AA3 ST-2 Stable Nov 30, 2024 Credit Rating Agency of Bangladesh Ltd. (CRAB) Dec 05, 2022 A1 ST-3 Stable Nov 30, 2023 Credit Rating Agency of Bangladesh Ltd. (CRAB)         Half Year End (HY) Information  202312 HY Net Turnover(mn)  5099.35 HY Net Profit after tax(mn)  751.89 HY EPS  3.25  AGM Information   AGM Date  24 December, 2023 Record Date  16 November, 2023 Dividend(%)  16.00(cash-June 2023) Bonus Issue  5% 2011

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2023	2.21	0	0	0	25.72	0	509.87	0	16%C	0.63
2022	4.05	0	0	0	25.73	0	935.04	0	16%C	0.62
2021	3.74	0	0	0	23.18	0	863.17	0	15%C	1.21
2020	1.65	0	0	0	20.04	0	380.69	0	6%C	0.99
2019	0.51	0	0	0	12.9	0	117.7	0	5%C	2.49

Financial Statements
Quarterly Financial Statement	https://www.beaconpharma.com.bd/financial-statements/
Price Sensitive Information	https://www.beaconpharma.com.bd/price-sensitive-informations/

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To